Suppr超能文献

手术治疗的肺鳞状细胞癌患者气腔播散的预后价值:一项荟萃分析。

Prognostic value of spread through air spaces in operated lung squamous cell carcinoma patients: A meta-analysis.

作者信息

Yuan Yuan, Yu Peng

机构信息

Department of Cardiothoracic Surgery, Xinjiang Military Region General Hospital, Urumqi, People's Republic of China.

Department of Cardiothoracic Surgery, XPCC Hospital, Urumqi, People's Republic of China.

出版信息

Medicine (Baltimore). 2025 Jun 20;104(25):e42940. doi: 10.1097/MD.0000000000042940.

Abstract

BACKGROUND

The presence of spread through air spaces (STAS) predicts poor long-term survival of lung cancer patients. However, the association between STAS and prognosis of operated lung squamous cell carcinoma (LSCC) remains unclear at this time. The aim of this meta-analysis was to further identify the prognostic value of STAS in surgical LSCC patients.

METHODS

Several electronic databases were searched up to April 12, 2025 for relevant studies. The primary and secondary outcomes were progression-free survival and overall survival/cancer-specific survival, respectively. The hazard ratios (HRs) and 95% confidence intervals (CIs) were combined and all statistical analyses were conducted by STATA 15.0 software.

RESULTS

A total of 9 studies involving 2884 cases were included and reviewed. The pooled results demonstrated that the presence of STAS was significantly associated with poor progression-free survival (HR = 1.84, 95% CI: 1.57-2.16, P< .001). Besides, STAS predicted poorer overall survival (HR = 1.75, 95% CI: 1.23-2.51, P = .002) and cancer-specific survival (HR = 1.73, 95% CI: 1.33-2.26, P < .001) in surgical LSCC.

CONCLUSION

Based on current evidence, STAS was identified as a novel and valuable prognostic risk factor for operated LSCC patients. However, more prospective high-quality studies are still needed to verify above findings.

摘要

背景

气腔播散(STAS)的存在预示着肺癌患者长期生存率较低。然而,目前STAS与手术切除的肺鳞状细胞癌(LSCC)预后之间的关联仍不明确。本荟萃分析的目的是进一步确定STAS在手术LSCC患者中的预后价值。

方法

检索多个电子数据库至2025年4月12日的相关研究。主要和次要结局分别为无进展生存期和总生存期/癌症特异性生存期。合并风险比(HRs)和95%置信区间(CIs),所有统计分析均使用STATA 15.0软件进行。

结果

共纳入并回顾了9项研究,涉及2884例病例。汇总结果表明,STAS的存在与较差的无进展生存期显著相关(HR = 1.84,95% CI:1.57 - 2.16,P <.001)。此外,STAS预示手术LSCC患者的总生存期较差(HR = 1.75,95% CI:1.23 - 2.51,P =.002)和癌症特异性生存期较差(HR = 1.73,95% CI:1.33 - 2.26,P <.001)。

结论

基于现有证据,STAS被确定为手术LSCC患者一种新的有价值的预后风险因素。然而,仍需要更多前瞻性高质量研究来验证上述发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca76/12187358/12957dafdbfb/medi-104-e42940-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验